SCHEMBL13601273

SCHEMBL13601273

Nc1nc(-c2ccn[nH]2)c2cnn(Cc3ccccc3F)c2n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 18/20 1.00
ADORA1 P30542 18/20 1.00
ADORA3 P0DMS8 5/20 0.68
ADORA2B P29275 5/20 0.68
HSP90AA1 P07900 1/20 0.45
HSP90AB1 P08238 1/20 0.45
TRAP1 Q12931 1/20 0.45
PDE5A O76074 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13707353 0.81 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL4459520 0.81 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL4462218 0.80 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL4455173 0.79 ADORA2A (0.70) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL13601285 0.79 ADORA2A (0.65) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL13601265 0.78 ADORA2A (0.64) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL4462290 0.78 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL4459559 0.78 ADORA2A (0.66) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL13601270 0.78 ADORA2A (0.71) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL4450557 0.77 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629349-B2 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2009-12-08 US disclosed
US-7629349-B2 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2009-12-08 US disclosed